Fruquintinib in Patients With Metastatic Colorectal Cancer

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 17, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Metastatic Colorectal Cancer (mCRC)
Trial Locations (1)

30161

RECRUITING

Onkologische Schwerpunktpraxis, Hanover

All Listed Sponsors
collaborator

Takeda GmbH

INDUSTRY

lead

iOMEDICO AG

INDUSTRY